Figure 1.
(A and B) Serial measurements of peripheral blood eosinophil count (A) and peak expiratory flow rate (B, prebronchodilator [red] and post-bronchodilator [blue]). The vertical dashed line indicates the time of benralizumab administration. The vertical solid line indicates the time of hospital discharge.